1) salvianolic acid A
丹参酚酸A
1.
Protective effects of salvianolic acid A on focal cerebral ischemia in rats;
丹参酚酸A、B对大鼠局灶性脑缺血损伤保护效应比较
2.
Quantitative determination of salvianolic acid A in rat plasma by HPLC;
HPLC法测定大鼠血浆中丹参酚酸A的浓度
3) Salvianolic acid B
丹参酚酸B
1.
Kinetics in the extraction process of Salvianolic acid B;
丹参酚酸B水提取动力学研究进展
2.
Stability of salvianolic acid B in water solution;
丹参酚酸B在水溶液中的稳定性研究
3.
Pharmacokinetics of salvianolic acid B after intravenous administration in rats;
大鼠静脉注射丹参酚酸B后的药代动力学研究(英文)
4) total salvianolic acids
丹参总酚酸
1.
Preparation and pharmaceutical properties of total salvianolic acids liposomes;
丹参总酚酸脂质体的制备和药剂学性质
2.
Result: Water soluble fractions, total salvianolic acids and salvianolic acid B markedly decreased ACE activity of rabbit lung tissue.
结果 :丹参水溶性部分、丹参总酚酸及丹酚酸B显著降低了大鼠肺组织的ACE活性 ,其IC50 分别为 ( 2 。
3.
In the present study, long circulating liposomes loaded with total salvianolic acids, lipophilic agents from traditional Chinese medicine danshen, were prepared in the aim of overcoming the limitations of traditional danshen preparations, such as instability, short circulation time and short effect time in vivo.
本文选择丹参总酚酸为模型药物，进行长循环脂质体的制备，以期解决其稳定性差、在血液循环中滞留时间短、体内作用时间短等问题，为开发疗效更好、生物利用度更高、服用更方便的丹参新制剂奠定基础，也为中药新型给药系统的制备和评价提供研究基础和科学依据。
5) Salvianolic acids
丹参总酚酸
1.
Determination of salvianolic acids in Salviae Miltiorrhizae and Ligustrazine for Injection by Spectrophotometry;
分光光度法测定注射用丹参川芎嗪中丹参总酚酸的含量
2.
The qualitative analysis and quantitative analysis of purification of salvianolic acids by macroreticular resin;
大孔吸附树脂纯化丹参总酚酸的定性定量分析
3.
Results and Conclusion Salvianolic acids is basicly stable, the CRH is about 45%.
目的研究丹参总酚酸的临界相对湿度及稳定性。
6) total salvianolic acid
丹参总酚酸
1.
Therapeutic effect of total salvianolic acid on mice with pulmonary fibrosis induced by Bleomycin;
丹参总酚酸对博莱霉素致肺纤维化小鼠的治疗作用
2.
Objective:To study the influence of total salvianolic acid(TSA) on the renal interstitial fibrosis caused by unilateral ureteral obstruction (UUO) in rats.
目的观察丹参总酚酸对单侧输尿管梗阻(UUO)大鼠肾间质纤维化的影响。
3.
OBJECTIVE To select the optimal ratio of the total salvianolic acid and astragalosides.
目的确定药对“丹参-黄芪”有效组分丹参总酚酸和黄芪总皂苷的最佳组方配比。
补充资料：丹参酚酸 B
分子式：C36H30O16
分子量：718.62
CAS号：115939-25-8
性质：
分子量：718.62
CAS号：115939-25-8
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条